Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation?
Protease inhibitors are useful tools for increasing the inhibitor potential of plasma. In this context, thrombin inhibitors attracted special interest. However, other clotting enzymes, especially factor Xa, are target enzymes of protease inhibitors besides thrombin. Our studies on structure-activity relationships of benzamidine derivatives resulted in selective inhibitors of thrombin and factor Xa. The use of these inhibitors enabled us to clarify whether the antithrombin activity or the anti-factor Xa activity of a compound is more efficient in anticoagulation. We assessed the concentration-dependent inhibition of the activated partial thromboplastin time by these compounds. If one correlates the inhibitor concentration, which prolonged the clotting time by 60 s, with the dissociation constants one will realize that thrombin inhibition is significantly more efficient in anticoagulation than inhibition of factor Xa.
Stürzebecher
J
J
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, GDR.
Stürzebecher
U
U
D000578:Amidines / Q000494:pharmacology*; D000925:Anticoagulants / Q000494:pharmacology*; D001550:Benzamidines / Q000031:analogs & derivatives / Q000494:pharmacology*; D015951:Factor Xa; D006801:Humans; D007700:Kinetics; D010314:Partial Thromboplastin Time; D012044:Regression Analysis; D015842:Serine Proteinase Inhibitors; D013329:Structure-Activity Relationship; D013917:Thrombin / Q000037:antagonists & inhibitors*
D000578:Amidines; D000925:Anticoagulants; D001550:Benzamidines; D015842:Serine Proteinase Inhibitors; D013917:Thrombin; D015951:Factor Xa